Subtype
Digestive System Adenocarcinoma
CI-CAN-00002525Explore in graph →
1,374 active trials24 approved drugs77 evidence items
- NCIt
- C210140
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002525Explore in graph →
Clinical trials
5,072 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (620)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03339843 | Multiorgan Metabolic Imaging Response Assessment of Abemaciclib(MiMe-A) | completed | Phase 2 | 85 | Jules Bordet InstituteOTHER | 2 | Mar 15, 2024 | clinicaltrials |
| NCT04451603 | LiverMultiScan Analysis of MRI Scans in HCC | completed | — | 21 | National Cancer Centre, SingaporeOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT05239507 | OREIOS International Study(OREIOS) | completed | — | 1,127 | AstraZenecaINDUSTRY | 11 | Mar 13, 2024 | clinicaltrials |
| NCT06030895 | Sorafenib In Egyptian Patients With Hepatocellular Carcinoma. | completed | N/A | 100 | Damanhour UniversityOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT06271980 | Early-Onset Colorectal Cancer Recurrence(ENCORE) | completed | — | 177 | City of Hope Medical CenterOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT04119362 | PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer(PARAGON) | completed | — | 469 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT06298123 | Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling | completed | — | 304 | Chen XiaopingOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT04618367 | HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT | completed | N/A | 30 | Sun Yat-sen UniversityOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT04627012 | Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma | completed | — | 600 | Sun Yat-sen UniversityOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT02182687 | Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant(SBRTvsTACE) | completed | Phase 2 | 60 | Lahey ClinicOTHER | 1 | Mar 5, 2024 | clinicaltrials |
| NCT04103398 | TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma(TREAT) | completed | Phase 3 | 162 | Sun Yat-sen UniversityOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06041425 | The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE | completed | Phase 4 | 40 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT05069766 | Preoperative Marking of the Oral Resection Margin in Esophageal Cancer With a Surgical Fiducial Marker - First Experiences | completed | N/A | 10 | Rigshospitalet, DenmarkOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT02859753 | Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency Ablation(Thermoablation) | completed | N/A | 35 | Centre Hospitalier Universitaire DijonOTHER | 1 | Feb 21, 2024 | clinicaltrials |
| NCT02830594 | Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer | completed | Phase 2 | 14 | City of Hope Medical CenterOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03047603 | Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC | completed | — | 4,005 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT05161013 | A Proof-of-Concept Study Evaluating LINFU™ | completed | N/A | 12 | Adenocyte, LLCINDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06265883 | Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT | completed | — | 205 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT04305067 | PRECISE: Pancreatic Cancer and Exercise | completed | N/A | 8 | Queen's University, BelfastOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT02918162 | Perioperative Chemo and Pembrolizumab in Gastric Cancer | completed | Phase 2 | 49 | Gulam ManjiOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT03990025 | Linked Color Imaging vs White Light Imaging for Detection of Gastric Cancer Precursors | completed | N/A | 90 | Changi General HospitalOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT06261138 | Survival Analysis: TACE vs. Combination Therapy in HCC | completed | — | 279 | Zhejiang UniversityOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT01959139 | S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer | completed | Phase 1 / Phase 2 | 126 | SWOG Cancer Research NetworkNETWORK | 1 | Feb 9, 2024 | clinicaltrials |
| NCT03893695 | Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC) | completed | Phase 1 / Phase 2 | 20 | Suzhou Kintor Pharmaceutical Inc,INDUSTRY | 1 | Feb 9, 2024 | clinicaltrials |
| NCT06245798 | Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension | completed | — | 3,000 | Tang-Du HospitalOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT04074343 | TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma | completed | Phase 1 | 20 | University of California, IrvineOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT06238752 | First-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GC(RENMIN-213) | completed | Phase 2 | 33 | Renmin Hospital of Wuhan UniversityOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT06233708 | Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant | completed | — | 2,092 | Asan Medical CenterOTHER | 0 | Jan 31, 2024 | clinicaltrials |
| NCT05074472 | A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors | completed | Phase 1 / Phase 2 | 35 | ZielBio, Inc.INDUSTRY | 1 | Jan 29, 2024 | clinicaltrials |
| NCT06199297 | Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma | completed | — | 188 | Sun Yat-sen UniversityOTHER | 1 | Jan 26, 2024 | clinicaltrials |
| NCT04406571 | Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer(CAPANCOVID-19) | completed | — | 700 | CHU de ReimsOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT02650271 | Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC | completed | Phase 3 | 240 | Guangxi Medical UniversityOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT03196232 | Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer | completed | Phase 2 | 3 | George Albert FisherOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT06216405 | Performance of Artificial Intelligence in Colonoscopy for Right Colon Polyp Detection(AIRCOP) | completed | N/A | 2,000 | Groupe Hospitalier Diaconesses Croix Saint-SimonOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT02329860 | Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP) | completed | Phase 3 | 400 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jan 22, 2024 | clinicaltrials |
| NCT03535259 | Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma(SIRAHCC) | completed | Phase 2 | 86 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jan 10, 2024 | clinicaltrials |
| NCT01004978 | Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | completed | Phase 3 | 235 | National Cancer Institute (NCI)NIH | 1 | Jan 3, 2024 | clinicaltrials |
| NCT01825603 | ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer | completed | Phase 1 | 17 | University of NebraskaOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT03783936 | Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas | completed | Phase 2 | 18 | Ashwin SomasundaramOTHER | 1 | Dec 19, 2023 | clinicaltrials |
| NCT00683631 | TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)(TheraSphere) | completed | — | 183 | University of LouisvilleOTHER | 1 | Dec 18, 2023 | clinicaltrials |
| NCT01624285 | Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer | completed | Phase 2 | 20 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 14, 2023 | clinicaltrials |
| NCT03006926 | A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma | completed | Phase 1 | 104 | Eisai Co., Ltd.INDUSTRY | 7 | Dec 13, 2023 | clinicaltrials |
| NCT05007548 | to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve | completed | Phase 2 | 30 | National Atomic Research Institute, TaiwanOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT00355238 | A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer | completed | Phase 2 | 137 | Bristol-Myers SquibbINDUSTRY | 8 | Dec 1, 2023 | clinicaltrials |
| NCT06147154 | Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients | completed | — | 23 | Qilu Hospital of Shandong UniversityOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT02287129 | Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction(MEMORI) | completed | Phase 2 | 75 | Technical University of MunichOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT05498779 | Ablation of Hepatocellular Carcinoma: a Nationwide Study | completed | — | 490 | Rigshospitalet, DenmarkOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT01447667 | Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA)(MRE) | completed | N/A | 72 | Seoul National University HospitalOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT01910909 | Stereotactic Body Radiotherapy for Unresectable Hepatocellular Carcinoma(SBRT for HCC) | completed | N/A | 56 | Samsung Medical CenterOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT02231723 | A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer | completed | Phase 1 | 139 | Sumitomo Pharma America, Inc.INDUSTRY | 1 | Nov 18, 2023 | clinicaltrials |
Data updated 24 days agoSource updated Mar 15, 2024source: clinicaltrials